We tested the hypothesis that genetic variation in ATM and BMI-1 genes can alter the risk of breast cancer through genotyping 6 variants among 524 breast cancer cases and 518 cancer-free controls of Han nationality. This was an observational, hospital-based, case-control association study. Analyses of single variant, linkage, haplotype, interaction and nomogram were performed. Risk was expressed as odds ratio (OR) and 95% confidence interval (CI). All studied variants were in the Hardy-Weinberg equilibrium and were not linked. The mutant allele frequencies of rs1890637, rs3092856 and rs1801516 in ATM gene were significantly higher in cases than in controls (P = .005,
widely applied to genetic association studies. 12, 13 Using this approach, we genotyped 2 candidate genes, HMGB1 and RAGE, and found a cumulative impact of multiple variants on breast cancer risk. 14 In this study, we focused on 2 cancer-predisposing genes, ATM and BMI-1, in association with breast cancer. The involvement of ATM and BMI-1 in carcinogenesis is biologically plausible. [15] [16] [17] [18] ATM is an acronym for ataxia telangiectasia mutated. ATM is a serine/threonine kinase involving in DNA damage repair, cell arrest and apoptosis, and chromatin remodelling. 19, 20 Genetic defects in ATM can cause multiple system dysfunctions and increase tumour susceptibility. [21] [22] [23] [24] BMI-1 is an acronym for B-cell-specific Moloney murine leukaemia virus integration site 1. BMI-1 is a polycomb protein that plays an important role in tumour cell development and maintaining stem cell populations of many cell lineages. 25 We therefore develop a hypothesis that ATM and BMI-1 genes are candidate genes of breast cancer. To test this hypothesis, we genotyped 4 variants in ATM gene and 2 variants in BMI-1 gene in 524 breast cancer cases and 518 cancer-free controls from Heilongjiang province, China to see whether they can alter the risk of breast cancer.
2 | ME TH ODS
| Study design
This is an observational, hospital-based, case-control, genetic association study, as previously reported. 14 
| Study participants
Only female participants who were Han Chinese were recruited in 
| Ethical approval
The conduct of this study was approved by the Ethics Committee of Qiqihar Medical University. Written informed consent was obtained from all study participants at the time of recruitment. This study complied with the Declaration of Helsinki.
| Breast cancer diagnosis
A patient was recorded to have breast cancer if he or she had either newly diagnosed or histopathologically confirmed or previously untreated breast cancer.
| Eligibility criteria
Control participants had no clinical evidence of any types of cancer except non-melanoma skin cancer. All controls reported to have no family history of cancer. No restriction was placed on age and tumour stage at the time of recruitment.
| Sample size
In total, 1042 female participants were eligible for inclusion. There were 524 cases with breast cancer and 518 controls free of cancer.
| Information collection
The following information was collected from cases with breast cancer, including age of first onset, age of menarche, menopausal age, family history of cancer, invasion depth (T1-T4), tumour stage (I-III) and lymph node. From controls free of cancer, age at enrolment and age of menarche were recorded.
| Phlebotomy
Venous blood samples (3 mL) were drawn into 5-mL vacutainer tubes containing K 3 -EDTA tubes from each participant. Plasma was separated by centrifugation at 4°C and kept frozen in a deep freezer at À80°C until assayed.
| DNA extraction
Genomic DNA was extracted from leucocytes using the phenol-cholesterol method according to a standard procedure.
| Variant selection
Four variants in ATM gene were selected, including rs189037 (A-111G), rs3092856 (1380His>Tyr or C4138T), rs1801516 (1853Asp>Asn) and rs373759 (126713G>A). Two variants were selected from BMI-1 gene, including rs1042059 (18Cys>Tyr) and rs201024480 (310Ser>Asn). The selection of these variants was based on published papers [25] [26] [27] [28] [29] [30] 
| Genotyping
Genomic sequences of 6 variants in ATM and BMI-1 genes were amplified by polymerase chain reaction. Genotyping was determined using ligase detection reaction method. 32 For each allele of a single variant, a specific probe was synthesized, and an additional common probe capped with 6-carboxy-fluorescein at the 3 0 end and with horylated at the 5 0 end was also synthesized. The primers and probes are available upon reasonable request.
Using the same method, 60 randomly selected samples were regenotyped, and the results were completely identical.
Genotyping was performed by laboratory workers in a manner blind to the case-control status and related characteristics of study participants. given the limited sample size of this study, an internal validation was performed by evenly and randomly splitting all study participants into 2 groups, viz. training group (n = 512) and testing group (n = 512). Risk prediction for breast cancer was, respectively, conducted in both groups.
| Statistical analyses
Linkage analysis was performed using the HaploView software 3 | RESULTS
| Baseline characteristics
This study involved 524 cases with breast cancer and 518 controls free of cancer. 
| Hardy-Weinberg equilibrium test
All studied variants were consistent with the distributions predicted by the Hardy-Weinberg equilibrium in controls (all P > .01).
| Linkage analysis
Linkage analysis indicated that the 4 variants in ATM gene and the 2 variants in BMI-1 gene were not correlated ( Figure S1 ). Table 2 shows the genotype and allele distributions/frequencies of 6 variants in ATM and BMI-1 gene. The mutant allele frequencies of rs1890637 (A), rs3092856 (T) and rs1801516 (A) were significantly higher in cases than in controls (P = .005, <.001 and .001, respectively). The genotype distributions differed remarkably significantly for rs3092856 and rs1801516 between cases and controls (both P < .001). The 2 variants, rs1042059 and rs201024480, in BMI-1 gene belonged to low-penetrance mutations, and there was no hint of significance with breast cancer risk. The genotype and allele comparisons of 6 studied variants between breast cancer cases, respectively, stratified by tumour stage, invasion depth, lymph node and controls are presented in Table S1 . of breast cancer after adjusting for age and age of menarche (Table 2) , and this association was retained in both training and testing groups, as shown in Table S2 . For all variants, the comparison of heterozygous genotype with wild homozygous genotype was nonsignificant in all study participants, as well as in both training and testing groups (Table S2 ).
| Single variant analysis
In the light of small number of mutant homozygotes for some variants, risk prediction for breast cancer was explored under additive and dominant models of inheritance ( (Table S3 ). In addition, the adjusted association of rs3092856 and rs1801516 with breast cancer was marginally significant, respectively, under the additive and dominant models (OR: 1.58 and 1.39, 95% CI: 1.04-2.39 and 1.00-1.93, P: .031 and .048), and significance persisted in both training and testing groups (Table S3 ).
| Haplotype analysis
Haplotype analysis was, respectively, conducted in ATM gene and BMI-1 gene, as they are mapped on different chromosomes. The derived haplotype frequencies and risk estimates for breast cancer are presented in Table 4 . In ATM gene, haplotype G-C-G-G (alleles arranged by order of rs189037, rs3092856, rs1801516 and rs373759, with the same hereafter) was the most common, and its frequency was significantly higher in controls than in cases (30.82% Other haplotypes carried no significance in association with breast cancer.
| Interaction analysis
The interaction of 6 studied variants is illustrated in Figure S2 
| Nomogram presentation
A nomogram calculator is presented in Figure 1 , by including age, family history, age of menarche as well as 3 significant variants (rs189037, rs3092856, rs1801516). The magnitude of age of OR, odds ratio; 95% CI, 95% confidence interval. *The P values were calculated after adjusting for age and age of menarche in a logistic regression analysis.
menarche was the strongest, following by family history, age, rs3092856, rs1801516 and rs189037. The cumulative contributory proportion of 3 significant variants to breast cancer was estimated to be 12.5%. The nomogram was somewhat good in prediction accuracy, with the C-index estimated to be 0.72 (P = .011). Data are expressed as odds ratio, 95% confidence interval, P value. *The P values were calculated after adjusting for age and age of menarche in a logistic regression analysis.
| DISCUSSION

T A B L E 4
Haplotype frequencies of variants in ATM and BMI1 genes between cases and controls, and haplotype-based risk prediction for breast cancer Haplotype* Hap-Score All, % Cases (n = 524), % Controls (n = 518), % Sim P value OR 95% lower limit 95% upper limit Hap-Score, haplotype score, Sim P value, simulated P value; OR, odds ratio. *In ATM gene, alleles are arranged according to the order of rs189037, rs3092856, rs1801516 and rs373759, and in BMI-1 gene, alleles are arranged according to the order of rs1042059 and rs201024480. In further haplotype analysis, we observed that that haplotype A-C-A-A carrying the mutations of both rs189037 (the 1st allele) and rs1801516 (the 3rd allele) was overrepresented in cases relative to controls, and its association with breast cancer was statistically significant. This observation not only reinforced the results of our single variant analysis, but also suggested the joint contribution of different loci in ATM gene on the development of breast cancer.
However, our interaction analysis of 6 studied variants in both ATM Several limitations should be considered in this study. First, this is an observational case-control association study, and our data cannot be used to prove the cause-effect relationship between ATM gene and breast cancer risk. Second, the coverage of genetic variation in ATM and BMI-1 genes was limited. Third, all participants were collected from 4 local hospitals, and multi-centre confounding cannot be ruled out. Fourth, this study involved only Chinese women of Han nationality, and extrapolation of our results to the other nationalities was only speculative.
Taken together, our findings indicated that ATM gene was a candidate gene in susceptibility to breast cancer in Han Chinese. This study suggests genetic heterogeneity in diverse racial groups and underscores the necessity for race-specific variation screening. In addition, our findings might be useful for the identification of highrisk youth women by genotyping ATM genetic variants before the cumulative exposure of obvious risk factors, and meanwhile this study offers some helpful hints in understanding the pathophysiology of breast cancer and other solid tumours.
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None declared. F I G U R E 1 Nomogram calculator in prediction for the risk of breast cancer. The magnitude of each factor in prediction for the risk of breast cancer can be estimated through drawing a vertical line from the measured value of each factor to the horizontal "Points" line, and each point is recorded. The total point is calculated by summing up all individual points and is marked on the horizontal "Total Points" line. Then, a vertical line starting from this total point is projected on the horizontal "Risk" line, and the value denotes the risk of having breast cancer 
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